Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell crawled time : 06:00 save search
CAR T-Cell Study Enabled by 10x Genomics Single Cell Technology Published in Nature Medicine
Published: 2023-07-06 (Crawled : 06:00) - biospace.com/
TXG | $28.83 -0.42% 370K
|
Health Technology
|
| O: -2.0%
H: 1.42%
C: 0.28%
t-cell genomics cell technology study
T-cell lymphoma Market 2026, Growing Geriatric Population to Boost Growth - Technavio
Published: 2022-09-26 (Crawled : 06:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 5.77%
H: 0.0%
C: -2.27%
AZNCF | $138.24 800
|
Health Technology
|
| O: -1.15%
H: 0.0%
C: -2.43%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -2.04%
H: 0.82%
C: 0.2%
BAX | $39.945 0.74% 430K
|
Health Technology
|
| O: -0.45%
H: 0.6%
C: -0.45%
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: -0.69%
H: 0.51%
C: -0.61%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -2.29%
H: 0.35%
C: -0.67%
BIIB | $191.45 0.49% 310K
|
Health Technology
|
| O: -0.17%
H: 1.2%
C: -0.86%
AUTL | $4.73 -1.46% 99K
|
Health Technology
|
| O: 2.94%
H: 1.43%
C: -0.48%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -1.52%
H: 0.48%
C: -1.36%
growing t-cell growth market
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
Published: 2021-12-28 (Crawled : 06:00) - globenewswire.com
NKTR | $1.275 -3.41% 270K
|
Health Technology
|
| O: -0.91%
H: 1.18%
C: -1.31%
therapeutics cel sars-cov-2 vaccine t-cell
Novartis provides update on BELINDA study investigating Kymriah® as second-line treatment in aggressive B-cell non-Hodgkin lymphoma
Published: 2021-08-24 (Crawled : 06:00) - globenewswire.com
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: -1.04%
treatment t-cell
Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across T-Cell Lymphomas
Published: 2021-02-03 (Crawled : 06:00) - globenewswire.com
IPHA | $2.35 2.3K
|
Health Technology
|
| O: 2.89%
H: 3.98%
C: 3.28%
t-cell potential pharma
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.